For 30 years, BioPlan has been a leading source of independent strategic information and analysis for the biopharmaceutical and life sciences. Strategic Consulting Delivering Integrity Trusted Expertise Respected Accuracy Learn More For 30 years, we’ve offered unbiased strategic market and customer informa...
Evaluation of industry capacity utilization in biomanufacturing. Determination of needs for education and training in life sciences and biotechnology segments. Due diligence for client considering investments into a $200 million market. Determination of market size for bacterial detection kit in veterinary m...
BioPlan Associates Releases New ReportRandi Hernandez
图1:对连续生物工艺和工艺强化的看法 资料来源:第20次生物制药产能报告与调查,BioPlan Associates,2023 年 4 月 调查受访者中比例最高的人(79%)积极回应(54.8% 同意,24.2% 强烈同意),他们将在未来五年内看到连续的商业生产设施。73% 的人达成了更多共识,预计一次性系统在连续下游生物工艺中会更加普遍。 灌流是...
自2020年新冠传染病爆发以来,生物制药/生物工艺行业在进行有效的应对过程中,也加剧了供应链挑战、人才短缺和行业区域化等问题,同时产生了新的战略发展需求。2021年在BioPlan Associates发表的18th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production,通过对包括25个国家的生物工艺行业单位的...
The BioPlan Associates 8th annual survey identifies key outsourcing concerns of sponsor companies and contractors.Eric S. LangerBiopharm International
资料来源:第20次生物制药产能报告与调查,BioPlan Associates,2023 年 4 月 在确定的2023年十大新产品开发领域中,CMO对连续下游技术,特别是层析技术,表现出特别的兴趣,超过50%表现出热情。这一兴趣水平在 CMO 的其它领域中是最高的,也是 CMO 和生物制造商对新产品开发领域兴趣比例最高的。
Further, as regulators gain familiarity with the safetyprofiles and materials used in these devices, necessary approvals for product manufacture will be facilitated, leading to a significant increase in the market volume for single usedevices.Editor/Contact: Lori Clapper...
functions concerning drugs in India.The CDA is expected to have separate, semi-autonomous depart- ments for regulation, enforcement, legal, and consumer affairs; biotechnology products; pharma- covigilance and drugs safety; med- ical devices and diagnostics; imports; quality control; and tradi- ...
Fig 1: Destination for Global Outsourcing “The President’s Cancer Moonshot needs to challenge existing thinking that manufacturing is about physical capacity,” said Eric Langer, managing partner at BioPlan Associates. “The full weight of the Federal Government could ignite the thinking required to...